Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Immunology | Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Infections and Infectious Diseases
Allergy Clinical Trials
A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (256) clinical trials
Moderate to Severe Atopic Dermatitis Clinical Research Study
Do you have moderate to severe Atopic Dermatitis?
Lupus Research Study
Local doctors are looking for adults struggling with lupus for clinical research studies of an investigational medication. Doctors are studying this medication to see if it may provide relief with common symptoms associated with lupus.
A Phase 3 Randomized Withdrawal, Double-blind, Placebo-controlled, Multi-center Study Investigating The Efficacy And Safety Of Pf-04965842 In Subjects Aged 12 Years And Over, With Moderate To Severe Atopic Dermatitis With The Option Of Rescue Treatment In Flaring Subjects
B7451014 is a Phase 3 study to investigate PF-04965842 in patients aged 12 years and over with a minimum body weight of 40 kg who have moderate to severe atopic dermatitis. Subjects responding well to an initial open-label 12 week treatment of PF-04965842 (200 mg) taken orally once daily (QD) ...
Chronic Itching from Eczema Study
“I Just Can’t Stop Scratching.” If you’ve said this to yourself before, you might qualify for a clinical study for a new investigational oral medication for the itching associated with atopic dermatitis. Atopic dermatitis patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scaring, infection, ...
Atopic Dermatitis
A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.
Eczema (Atopic Dermatitis)
Do you or a loved one have eczema (also called "atopic dermatitis")? If so, you might be interested in a clinical study now enrolling. Wake Research is testing a study drug for eczema and we need people to take part.
A Phase 2/3 Study Investigating the Pharmacokinetics, Safety, and Efficacy of Dupilumab in Patients Aged 6 Months or Older to <6 Years With Severe Atopic Dermatitis
This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD).
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly With Topical Corticosteroids in Patients, 6 Years or Older to <12 Years of Age, With Severe Atopic Dermatitis
The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 ...
